Cargando…
New pricing models for generic medicines to ensure long-term sustainable competition in Europe
Background: Price erosion of generic medicines over time as a result of existing pricing policies in combination with increasing operational costs of these products due to high inflation, undermine long-term sustainable competition in European off-patent medicines markets. Therefore, the aim of this...
Autores principales: | Francois, Clement, Gawlik, Gabriela, Mestre-Ferrandiz, Jorge, Pana, Adrian, Perelman, Julian, Yfantopoulos, John, Simoens, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593415/ https://www.ncbi.nlm.nih.gov/pubmed/37876734 http://dx.doi.org/10.3389/fphar.2023.1200641 |
Ejemplares similares
-
Not one, but many: developing a multi-indication pricing model for medicines in Belgium
por: Maes, Ingrid, et al.
Publicado: (2023) -
Generic Medicine Pricing Policies in Europe: Current Status and Impact
por: Dylst, Pieter, et al.
Publicado: (2010) -
A Comparative Analysis of Pricing and Reimbursement of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Europe
por: Abdallah, Khadidja, et al.
Publicado: (2021) -
Different initiatives across Europe to enhance losartan utilization post generics: impact and implications
por: Moon, James C., et al.
Publicado: (2014) -
Biosimilar competition in European markets of TNF-alpha inhibitors: a comparative analysis of pricing, market share and utilization trends
por: Car, Elif, et al.
Publicado: (2023)